Matches in Wikidata for { <http://www.wikidata.org/entity/Q91998018> ?p ?o ?g. }
Showing items 1 to 43 of
43
with 100 items per page.
- Q91998018 description "artículu científicu espublizáu en mayu de 2019" @default.
- Q91998018 description "scientific article published on 28 May 2019" @default.
- Q91998018 description "wetenschappelijk artikel" @default.
- Q91998018 description "наукова стаття, опублікована 28 травня 2019" @default.
- Q91998018 name "A phase Ib study of the combination of afatinib and ruxolitinib in EGFR mutant NSCLC with progression on EGFR-TKIs" @default.
- Q91998018 name "A phase Ib study of the combination of afatinib and ruxolitinib in EGFR mutant NSCLC with progression on EGFR-TKIs" @default.
- Q91998018 type Item @default.
- Q91998018 label "A phase Ib study of the combination of afatinib and ruxolitinib in EGFR mutant NSCLC with progression on EGFR-TKIs" @default.
- Q91998018 label "A phase Ib study of the combination of afatinib and ruxolitinib in EGFR mutant NSCLC with progression on EGFR-TKIs" @default.
- Q91998018 prefLabel "A phase Ib study of the combination of afatinib and ruxolitinib in EGFR mutant NSCLC with progression on EGFR-TKIs" @default.
- Q91998018 prefLabel "A phase Ib study of the combination of afatinib and ruxolitinib in EGFR mutant NSCLC with progression on EGFR-TKIs" @default.
- Q91998018 P1433 Q91998018-153E4B2B-3DB6-446B-80EB-4544EBA2F3D5 @default.
- Q91998018 P1476 Q91998018-73386903-8876-4CE3-8A49-09BBDB25114C @default.
- Q91998018 P2093 Q91998018-21E50D39-A5A3-436E-AD87-1EBD5E94198E @default.
- Q91998018 P2093 Q91998018-3DF420F5-88A7-4C7A-A184-FA93F7875355 @default.
- Q91998018 P2093 Q91998018-744B0B3F-0574-4F7C-8735-A04A469DB067 @default.
- Q91998018 P304 Q91998018-448FDCC7-166C-46A7-927B-480A70B973C3 @default.
- Q91998018 P31 Q91998018-CA13A578-6B87-4685-A07A-41156AFB545C @default.
- Q91998018 P356 Q91998018-3A9A909F-6BA5-4D23-ADBE-45285D859E7E @default.
- Q91998018 P478 Q91998018-F9A53F0B-3183-424E-AC22-AA7BE40F59BE @default.
- Q91998018 P50 Q91998018-CD5CF462-7009-441A-8314-7EC44110875D @default.
- Q91998018 P50 Q91998018-FF76B908-8B89-4249-97C5-D3D3D5AA38D0 @default.
- Q91998018 P577 Q91998018-470D4B39-19FB-47FC-8D80-3FE4160EAF02 @default.
- Q91998018 P698 Q91998018-9AB779F0-B7B4-4E67-A879-592ACAB7801D @default.
- Q91998018 P921 Q91998018-180E2062-43B8-484F-9E50-6574B94D1D59 @default.
- Q91998018 P921 Q91998018-6C5F2680-C7BC-44DB-BFF9-AE53AAB1577C @default.
- Q91998018 P356 J.LUNGCAN.2019.05.030 @default.
- Q91998018 P698 31319994 @default.
- Q91998018 P1433 Q641464 @default.
- Q91998018 P1476 "A phase Ib study of the combination of afatinib and ruxolitinib in EGFR mutant NSCLC with progression on EGFR-TKIs" @default.
- Q91998018 P2093 "Hye Ryun Kim" @default.
- Q91998018 P2093 "Ji Soo Park" @default.
- Q91998018 P2093 "You Jin Chun" @default.
- Q91998018 P304 "46-51" @default.
- Q91998018 P31 Q13442814 @default.
- Q91998018 P356 "10.1016/J.LUNGCAN.2019.05.030" @default.
- Q91998018 P478 "134" @default.
- Q91998018 P50 Q57566753 @default.
- Q91998018 P50 Q63775110 @default.
- Q91998018 P577 "2019-05-28T00:00:00Z" @default.
- Q91998018 P698 "31319994" @default.
- Q91998018 P921 Q3658562 @default.
- Q91998018 P921 Q7383611 @default.